CELEX: 62019TN0104
Language: en
Date: 2019-02-19 00:00:00
Title: Case T-104/19: Action brought on 19 February 2019 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)

15.4.2019   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 139/85
            
         
      Action brought on 19 February 2019 — Dermavita v EUIPO — Allergan Holdings France (JUVÉDERM)
      (Case T-104/19)
      (2019/C 139/86)
      Language of the case: English
      
         Parties
      
      
         Applicant: Dermavita Co. Ltd (Beirut, Lebanon) (represented by: G. Paricheva, lawyer)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: Allergan Holdings France SAS (Courbevoie, France)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
      
         Trade mark at issue: European Union word mark JUVÉDERM — European Union trade mark No 5 807 169
      
         Procedure before EUIPO: Cancellation proceedings
      
         Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 19 December 2018 in Case R 2630/2017-4
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision;
               
            
                  —
               
               
                  order EUIPO and the other party to the proceedings before the Board of Appeal to bear their own costs and pay those of the applicant for annulment at every stage of the action for revocation and appeal proceedings, including the cost of these proceedings.
               
            
         Plea in law
      
      
                  —
               
               
                  Infringement of Article 18 of Regulation (EU) 2017/1001 of the European Parliament and of the Council.